Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Candesartan cilexetil/olmesartan medoxomil/valsartan

Renal impairment and hypocalvaria following in utero exposure: 7 case reports

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Hunseler C, Paneitz A, Friedrich D, Lindner U, Oberthuer A, Korber F, Schmitt K, Welzing L, Muller A, Herkenrath P, Hoppe B, Gortner L, Roth B, Kattner E, Schaible T.Angiotensin II receptor blocker induced fetopathy: 7 cases. Klinische Padiatrie 223: 10-14, No. 1, Jan 2011. Available from: URL: http://dx.doi.org/10.1055/s-0030-1269895 - Germany

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Candesartan cilexetil/olmesartan medoxomil/valsartan. React. Wkly. 1341, 11 (2011). https://doi.org/10.2165/00128415-201113410-00035

    Download citation

    Keywords

    • Nitric Oxide
    • Pulmonary Hypertension
    • Renal Impairment
    • Valsartan
    • Candesartan